Einrichtungen, die zum Universitätsklinikum Erlangen gehören

Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis (2019) Yarmolinsky J, Relton CL, Lophatananon A, Muir K, Menon U, Gentry-Maharaj A, Walther A, et al. Journal article Costs associated with multidrug-resistance in inpatient palliative care (2019) Adelhardt T, Hessemer S, Heckel M, Herbst FA, Stiel S, Ostgathe C, Schöffski O Journal article Gluten and FODMAPS-sense of a restriction/when is restriction necessary? (2019) Dieterich W, Zopf Y Journal article, Original article Limited Effect of Anti-PD-1 in advanced Skin Tumors of Patients with hemato-oncological Primary Disease: A retrospective multi-center Study of ADO (2019) Leiter-Stoeppke U, Loquai C, Meier F, Rafei-Shamsabadi D, Hassel J, Glutsch V, Sirokay J, et al. Conference contribution Association of an initial Exanthem with Vemurafenib and Cobimetinib for a better Therapeutic Success in metastatic Melanoma Patients (2019) Kaehler K, Bohne AS, Gutzmer R, Satzger I, Meier F, Reinhardt L, Zimmer L, et al. Conference contribution Lipase Elevations and Diabetes under Checkpoint Inhibition - Experience in 80 Patients (2019) Weihkopf D, Satzger I, Zimmer L, Eigentler T, Haessel J, Heinzerling L, Herbst R, et al. Conference contribution The WISE-CRT System Leads to Left Ventricular Remodeling and Improved Symptoms in Patients Who are Non-Responders to Epicardial CRT (2019) Sidhu BS, Gould J, Porter B, Turley A, Diemberger I, Biffi M, Seifert M, et al. Conference contribution The WiSE-CRT System Results in Left Ventricular Remodelling and Improved Symptoms in Patients Undergoing CRT Upgrades (2019) Sidhu BS, Gould J, Porter B, Diemberger I, Biffi M, Seifert M, Butter C, et al. Conference contribution Patients Undergoing High-Risk CRT Upgrades with a WiSE-CRT System Have at Trend towards Improved Left Ventricular Remodelling Compared with Epicardial CRT Upgrades (2019) Sidhu BS, Gould J, Porter B, Diemberger I, Biffi M, Seifert M, Butter C, et al. Conference contribution Characterization of Patients with inoperable malignant Stage IIIB-D Melanoma (2019) Zaremba A, Weishaupt C, Glutsch V, Schilling B, Loquai C, Rafei-Shamsabadi D, Meiss F, et al. Conference contribution